4-(azetidine-1-carbonyl)-N-[2-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1-methylpyrazole-5-carboxamide
C22H21N7O3 — CID 165415238
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(azetidine-1-carbonyl)-N-[2-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1-methylpyrazole-5-carboxamide
4-(azetidine-1-carbonyl)-N-[2-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1-methylpyrazole-5-carboxamide (PubChem CID 165415238) has the molecular formula C22H21N7O3 and a molecular weight of 431.46 g/mol. Its IUPAC name is 4-(azetidine-1-carbonyl)-N-[2-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1-methylpyrazole-5-carboxamide.
Molecular Properties
| Compound Name | 4-(azetidine-1-carbonyl)-N-[2-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1-methylpyrazole-5-carboxamide |
|---|---|
| PubChem CID | 165415238 |
| Molecular Formula | C22H21N7O3 |
| Molecular Weight | 431.46 g/mol |
| Exact Mass | 431.17 |
| IUPAC Name | 4-(azetidine-1-carbonyl)-N-[2-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-1-methylpyrazole-5-carboxamide |
| SMILES | COc1ccc(-c2nc3cc(NC(=O)c4c(C(=O)N5CCC5)cnn4C)ccn3n2)cc1 |
| InChI | InChI=1S/C22H21N7O3/c1-27-19(17(13-23-27)22(31)28-9-3-10-28)21(30)24-15-8-11-29-18(12-15)25-20(26-29)14-4-6-16(32-2)7-5-14/h4-8,11-13H,3,9-10H2,1-2H3,(H,24,30) |
| InChIKey | SIWVOCWZVDYKBI-UHFFFAOYSA-N |
| XLogP | 2.24 |
| TPSA | 106.65 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 431.46 |
| LogP ≤ 5 | 2.24 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165415238 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.